Motley Fool Asset Management LLC Biomarin Pharmaceutical Inc Transaction History
Motley Fool Asset Management LLC
- $1.66 Billion
- Q3 2024
A detailed history of Motley Fool Asset Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Motley Fool Asset Management LLC holds 148,798 shares of BMRN stock, worth $10 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
148,798
Previous 150,739
1.29%
Holding current value
$10 Million
Previous $12.4 Million
15.72%
% of portfolio
0.63%
Previous 0.85%
Shares
19 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.53 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.3 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.27 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$936 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$707 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...